Literature DB >> 18574240

Functional characterization of fingers subdomain-specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase.

Andrei Nikonov1, Erkki Juronen, Mart Ustav.   

Abstract

The hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp), encoded by nonstructural protein 5B (NS5B), is absolutely essential for the viral replication. Here we describe the development, characterization, and functional properties of the panel of monoclonal antibodies (mAbs) and specifically describe the mechanism of action of two mAbs inhibiting the NS5B RdRp activity. These mAbs recognize and bind to distinct linear epitopes in the fingers subdomain of NS5B. The mAb 8B2 binds the N-terminal epitope of the NS5B and inhibits both primer-dependent and de novo RNA synthesis. mAb 8B2 selectively inhibits elongation of RNA chains and enhances the RNA template binding by NS5B. In contrast, mAb 7G8 binds the epitope that contains motif G conserved in viral RdRps and inhibits only primer-dependent RNA synthesis by specifically targeting the initiation of RNA synthesis, while not interfering with the binding of template RNA by NS5B. To reveal the importance of the residues of mAb 7G8 epitope for the initiation of RNA synthesis, we performed site-directed mutagenesis and extensively characterized the functionality of the HCV RdRp motif G. Comparison of the mutation effects in both in vitro primer-dependent RdRp assay and cellular transient replication assay suggested that mAb 7G8 epitope amino acid residues are involved in the interaction of template-primer or template with HCV RdRp. The data presented here allowed us to describe the functionality of the epitopes of mAbs 8B2 and 7G8 in the HCV RdRp activity and suggest that the epitopes recognized by these mAbs may be useful targets for antiviral drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18574240      PMCID: PMC3259772          DOI: 10.1074/jbc.M803422200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  RNA synthesis in a cage--structural studies of reovirus polymerase lambda3.

Authors:  Yizhi Tao; Diane L Farsetta; Max L Nibert; Stephen C Harrison
Journal:  Cell       Date:  2002-11-27       Impact factor: 41.582

2.  FPLC purification of mouse monoclonal antibodies from ascitic fluid using blue DEAE and thiophilic sorbents.

Authors:  E Juronen; J Parik; P Toomik
Journal:  J Immunol Methods       Date:  1991-01-24       Impact factor: 2.303

3.  Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.

Authors:  H Huang; R Chopra; G L Verdine; S C Harrison
Journal:  Science       Date:  1998-11-27       Impact factor: 47.728

4.  Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives.

Authors:  Baohua Gu; Victor K Johnston; Lester L Gutshall; Tammy T Nguyen; Richard R Gontarek; Michael G Darcy; Rosanna Tedesco; Dashyant Dhanak; Kevin J Duffy; C Cheng Kao; Robert T Sarisky
Journal:  J Biol Chem       Date:  2003-01-27       Impact factor: 5.157

5.  A relaxed discrimination of 2'-O-methyl-GTP relative to GTP between de novo and Elongative RNA synthesis by the hepatitis C RNA-dependent RNA polymerase NS5B.

Authors:  Hélène Dutartre; Joëlle Boretto; Jean Claude Guillemot; Bruno Canard
Journal:  J Biol Chem       Date:  2004-11-22       Impact factor: 5.157

6.  Mutational analysis of the structure and functions of hepatitis C virus RNA-dependent RNA polymerase.

Authors:  W Qin; T Yamashita; Y Shirota; Y Lin; W Wei; S Murakami
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

7.  Template requirement and initiation site selection by hepatitis C virus polymerase on a minimal viral RNA template.

Authors:  J W Oh; G T Sheu; M M Lai
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

8.  Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Darius Moradpour; Elke Bieck; Thomas Hügle; Winfried Wels; Jim Zhen Wu; Zhi Hong; Hubert E Blum; Ralf Bartenschlager
Journal:  J Biol Chem       Date:  2001-10-18       Impact factor: 5.157

Review 9.  Allosteric inhibition of the hepatitis C virus NS5B RNA dependent RNA polymerase.

Authors:  Uwe Koch; Frank Narjes
Journal:  Infect Disord Drug Targets       Date:  2006-03

10.  Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme.

Authors:  Robert A Love; Hans E Parge; Xiu Yu; Michael J Hickey; Wade Diehl; Jingjin Gao; Hilary Wriggers; Anne Ekker; Liann Wang; James A Thomson; Peter S Dragovich; Shella A Fuhrman
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  6 in total

Review 1.  Progress towards recombinant anti-infective antibodies.

Authors:  Jennifer C Pai; Jamie N Sutherland; Jennifer A Maynard
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2009-01

Review 2.  Dynamics: the missing link between structure and function of the viral RNA-dependent RNA polymerase?

Authors:  Craig E Cameron; Ibrahim M Moustafa; Jamie J Arnold
Journal:  Curr Opin Struct Biol       Date:  2009-11-10       Impact factor: 6.809

3.  Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone.

Authors:  Partha K Chandra; Sidhartha Hazari; Bret Poat; Feyza Gunduz; Ramesh Prabhu; Gerald Liu; Roberto Burioni; Massimo Clementi; Robert F Garry; Srikanta Dash
Journal:  Virol J       Date:  2010-06-07       Impact factor: 4.099

4.  RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications.

Authors:  Margit Mutso; Andrei Nikonov; Arno Pihlak; Eva Žusinaite; Liane Viru; Anastasia Selyutina; Tõnu Reintamm; Merike Kelve; Mart Saarma; Mati Karelson; Andres Merits
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

5.  Dissection of two drug-targeted regions of Hepatitis C virus subtype 4a infecting Egyptian patients.

Authors:  Radwa R El-Tahan; Ahmed M Ghoneim; Hosam Zaghloul
Journal:  Virus Genes       Date:  2020-06-22       Impact factor: 2.332

6.  Globular domain structure and function of restriction-like-endonuclease LINEs: similarities to eukaryotic splicing factor Prp8.

Authors:  M Murshida Mahbub; Saiful M Chowdhury; Shawn M Christensen
Journal:  Mob DNA       Date:  2017-11-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.